Zhejiang Medicine Co.,Ltd.’s Net Profit Rose 16.1% in First Three Quarters of 2021

Zhejiang Medicine Co.,Ltd. (浙江医药股份有限公司) (600216.SH) reported a net profit of 685.9 million yuan in the first three quarters of 2021, up 16.1% year-on-year.

Meanwhile, the company posted 6.8 billion yuan in revenue, up 25.5% year-on-year.

At the end of the reporting period, it had 11.9 billion yuan in total assets and 3 billion yuan in total liabilities, with a liability-to-asset ratio of 25.3%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.